Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2350
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy ; volume:11 ; number:1 ; day:30 ; month:4 ; year:2010 ; pages:1-10 ; date:12.2010
BMC medical genetics ; 11, Heft 1 (30.4.2010), 1-10, 12.2010
- Urheber
-
Rodríguez-García, María Isabel
- Beteiligte Personen und Organisationen
-
Monserrat, Lorenzo
Ortiz, Martín
Fernández, Xusto
Cazón, Laura
Núñez, Lucía
Barriales-Villa, Roberto
Maneiro, Emilia
Veira, Elena
Castro-Beiras, Alfonso
Hermida-Prieto, Manuel
SpringerLink (Online service)
- DOI
-
10.1186/1471-2350-11-67
- URN
-
urn:nbn:de:1111-2016071511454
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rodríguez-García, María Isabel
- Monserrat, Lorenzo
- Ortiz, Martín
- Fernández, Xusto
- Cazón, Laura
- Núñez, Lucía
- Barriales-Villa, Roberto
- Maneiro, Emilia
- Veira, Elena
- Castro-Beiras, Alfonso
- Hermida-Prieto, Manuel
- SpringerLink (Online service)
Ähnliche Objekte (12)
MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy